Terms: = Ovarian cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
133 results:
1. Noscapine and Apoptosis in Breast and Other cancers.
Calaf GM; Crispin LA; Quisbert-Valenzuela EO
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
[TBL] [Abstract] [Full Text] [Related]
2. Glycemic load, but not glycemic index, is associated with an increased risk of ovarian cancer: A systematic review and meta-analysis.
Zhu L; Shu Y; Ran J; Zhang C
Nutr Res; 2024 Mar; 123():67-79. PubMed ID: 38281319
[TBL] [Abstract] [Full Text] [Related]
3. Characteristics and survival of patients with gynecological cancers who refuse radiotherapy: a retrospective cohort study.
Zhang S; He J; Liu J
BMC Womens Health; 2023 Nov; 23(1):562. PubMed ID: 37915037
[TBL] [Abstract] [Full Text] [Related]
4. Exploration of pyroptosis-associated prognostic gene signature and lncRNA regulatory network in ovarian cancer.
Zhang B; Li Z; Wang K; Duan M; Yin Y; Zhan Q; Wang F; An R
Comput Biol Med; 2023 Sep; 164():107343. PubMed ID: 37566932
[TBL] [Abstract] [Full Text] [Related]
5. Overall survival prediction models for gynecological endometrioid adenocarcinoma with squamous differentiation (GE-ASqD) using machine-learning algorithms.
Liu X; Jin S; Zi D
Sci Rep; 2023 May; 13(1):8395. PubMed ID: 37225749
[TBL] [Abstract] [Full Text] [Related]
6. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract] [Full Text] [Related]
7. Familial aggregation of early-onset cancers in early-onset breast cancer families.
Rantala JNJ; Heikkinen SMM; Hirvonen EM; Tanskanen T; Malila NK; Pitkäniemi JM
Int J Cancer; 2023 Jul; 153(2):331-340. PubMed ID: 37074269
[TBL] [Abstract] [Full Text] [Related]
8. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial.
Waterhouse M; Ebeling PR; McLeod DSA; English D; Romero BD; Baxter C; Armstrong BK; Hartel G; Kimlin M; O'Connell RL; van der Pols JC; Venn AJ; Webb PM; Whiteman DC; Neale RE
Lancet Diabetes Endocrinol; 2023 May; 11(5):324-332. PubMed ID: 37011645
[TBL] [Abstract] [Full Text] [Related]
9. VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
Jlassi A; Manai M; Morjen M; Sahraoui G; Elasmi Allal M; ELBini-Dhouib I; Naija L; Charfi L; Rejaibi R; Ben Ahmed M; Marrakchi N; Srairi-Abid N; Mezlini A; Manai M; Mrad K; Doghri R
PLoS One; 2023; 18(3):e0278849. PubMed ID: 36952478
[TBL] [Abstract] [Full Text] [Related]
10. Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials.
Purwar R; Ranjan R; Soni K; Pandey M; Upadhyay SK; Pai E; Kumar T
World J Surg Oncol; 2022 Nov; 20(1):367. PubMed ID: 36419077
[TBL] [Abstract] [Full Text] [Related]
11. Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis.
Ellwanger B; Schüler-Toprak S; Jochem C; Leitzmann MF; Baurecht H
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1618. PubMed ID: 35384414
[TBL] [Abstract] [Full Text] [Related]
12. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract] [Full Text] [Related]
13. Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
Kim SR; Tone A; Kim RH; Cesari M; Clarke BA; Eiriksson L; Hart TL; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE
Cancer; 2021 Sep; 127(17):3082-3091. PubMed ID: 33983630
[TBL] [Abstract] [Full Text] [Related]
14. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
[TBL] [Abstract] [Full Text] [Related]
15. Endometrial cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
de Jonge MM; de Kroon CD; Jenner DJ; Oosting J; de Hullu JA; Mourits MJE; Gómez Garcia EB; Ausems MGEM; Margriet Collée J; van Engelen K; van de Beek I; ; Smit VTHBM; Rookus MA; de Bock GH; van Leeuwen FE; Bosse T; Dekkers OM; van Asperen CJ
J Natl Cancer Inst; 2021 Sep; 113(9):1203-1211. PubMed ID: 33710348
[TBL] [Abstract] [Full Text] [Related]
16. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract] [Full Text] [Related]
17. Spotlight on oncologic outcomes and prognostic factors of pure endometrioid ovarian carcinoma.
Cakir C; Korkmaz V; Kimyon Comert G; Yuksel D; Kilic F; Kilic C; Turkmen O; Turan T
J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):102105. PubMed ID: 33705993
[TBL] [Abstract] [Full Text] [Related]
18. Association of Risk-Reducing Salpingo-Oophorectomy With Breast cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.
Choi YH; Terry MB; Daly MB; MacInnis RJ; Hopper JL; Colonna S; Buys SS; Andrulis IL; John EM; Kurian AW; Briollais L
JAMA Oncol; 2021 Apr; 7(4):585-592. PubMed ID: 33630024
[TBL] [Abstract] [Full Text] [Related]
19. ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
[TBL] [Abstract] [Full Text] [Related]
20. Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous ovarian Adenocarcinoma.
Kutilin DS; Tsandekova MR; Porkhanova NV
Bull Exp Biol Med; 2021 Jan; 170(3):332-339. PubMed ID: 33452985
[TBL] [Abstract] [Full Text] [Related]
[Next]
